US Patent 8080516 Long lasting synthetic exendin-4 peptide conjugates
Patent 8080516 was granted and assigned to ConjuChem on December, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+445 characters)
Article
Patent abstract
Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Anouk LeBlanc0
Benoit L'Archeveque0
Darren L. Holmes0
Dominique P. Bridon0
Serge St. Pierre0
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08080516 Long lasting synthetic exendin-4 peptide conjugates US Patent 8080516 Long lasting synthetic exendin-4 peptide conjugates
Infobox
Patent Number
080805160
Patent Number
80805160
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080805160
Date of Patent
December 20, 2011
0Patent Application Number
111709670
Date Filed
June 29, 2005
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08080516 Long lasting synthetic exendin-4 peptide conjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08080516
Date of patent
December 20, 2011
Patent application number
11170967
Date Filed
June 29, 2005
Patent primary examiner
Find more entities like US Patent 8080516 Long lasting synthetic exendin-4 peptide conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.